Palisade Bio, Inc. Reports Board Changes
Ticker: PALI · Form: 8-K · Filed: Sep 5, 2025 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Sep 5, 2025 |
| Risk Level | low |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $0.01, $575,000, $298,500, $440,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, board-of-directors
TL;DR
Board shakeup at Palisade Bio, Inc. - new director in, one out.
AI Summary
Palisade Bio, Inc. announced on September 4, 2025, a change in its board of directors. Specifically, the company reported the departure of a director and the election of a new director, effective September 4, 2025. The filing also touches upon compensatory arrangements for certain officers.
Why It Matters
Changes in a company's board of directors can signal shifts in strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance changes and does not appear to involve significant financial transactions or operational disruptions.
Key Players & Entities
- PALISADE BIO, INC. (company) — Registrant
- September 4, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-33672 (company_id) — Commission File Number
- 52-2007292 (company_id) — IRS Employer Identification No.
- Seneca Biopharma, Inc. (company) — Former Company Name
- 20200127 (date) — Date of Former Company Name Change
- Neuralstem, Inc. (company) — Former Company Name
- 20060324 (date) — Date of Former Company Name Change
FAQ
What specific changes occurred regarding the board of directors on September 4, 2025?
The filing indicates the departure of a director and the election of a new director, effective September 4, 2025.
What other item is covered in this 8-K filing besides director changes?
The filing also covers compensatory arrangements of certain officers.
What is the exact name of the company filing this report?
The exact name of the registrant is PALISADE BIO, INC.
In which state was Palisade Bio, Inc. incorporated?
Palisade Bio, Inc. was incorporated in Delaware.
What were the previous names of Palisade Bio, Inc. and when did those name changes occur?
The company was formerly known as Seneca Biopharma, Inc. (name change effective 20200127) and Neuralstem, Inc. (name change effective 20060324).
Filing Stats: 2,123 words · 8 min read · ~7 pages · Grade level 12.9 · Accepted 2025-09-05 09:00:42
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share PALI Nasdaq Capital Mark
- $575,000 — r. Finley will receive a base salary of $575,000 per year, subject to Board review. El
- $298,500 — e will receive an annual base salary of $298,500, with eligibility for review and adjust
- $440,000 — Dr. Jones will receive a base salary of $440,000 per year, subject to adjustment by the
Filing Documents
- form8-k.htm (8-K) — 77KB
- 0001493152-25-012687.txt ( ) — 243KB
- pali-20250904.xsd (EX-101.SCH) — 3KB
- pali-20250904_lab.xml (EX-101.LAB) — 33KB
- pali-20250904_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 5, 2025 Palisade Bio, Inc. /s/ J.D. Finley By: J.D. Finley Chief Executive Officer